Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01890902

Efficacy and Safety of Impracor (Ketoprofen 10% Cream) Compared With Placebo in the Treatment of Acute Pain (Flare) Associated With Osteoarthritis of the Knee

A Randomized, Multicenter, Double-Blind, Parallel-Group Study to Assess the Efficacy and Safety of Impracor (Ketoprofen 10% Cream) Compared With Placebo in the Treatment of Acute Pain (Flare) Associated With Osteoarthritis of the Knee

Status
Withdrawn
Phase
Phase 3
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Imprimis Pharmaceuticals, Inc. · Industry
Sex
All
Age
35 Years
Healthy volunteers
Not accepted

Summary

The primary objective of the study is to assess analgesic efficacy of Impracor (Ketoprofen 10% Cream) compared to placebo for acute pain associated with OA flare of the knee.

Conditions

Interventions

TypeNameDescription
DRUGKetoprofen 10% Cream
DRUGPlacebo

Timeline

Start date
2013-08-01
Primary completion
2014-06-01
First posted
2013-07-02
Last updated
2013-11-13

Source: ClinicalTrials.gov record NCT01890902. Inclusion in this directory is not an endorsement.

Efficacy and Safety of Impracor (Ketoprofen 10% Cream) Compared With Placebo in the Treatment of Acute Pain (Flare) Asso (NCT01890902) · Clinical Trials Directory